CURE — Biocure Technology Balance Sheet

0.000.00%

Last trade - 00:00

EnergyHighly SpeculativeMicro Cap

Annual balance sheet for Biocure Technology, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.109	0.132	0.047	0.159	0.038
Net Total Accounts Receivable
Net Total Receivables	0.033	0.089	0.071	1.9	0.022
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.182	0.234	0.136	2.13	0.118
Net Property, Plant And Equipment	0.165	0.107	0.086	0.008	0
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	3.62	4.58	4.55	4.15	2.08
Payable / Accrued
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.91	2.21	3.94	3.75	4.41
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Liabilities	2.72	4.87	6.55	4.69	4.06
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	0.901	-0.291	-2	-0.533	-1.98
Total Liabilities & Shareholders' Equity	3.62	4.58	4.55	4.15	2.08
Total Common Shares Outstanding